为了满足您的需求，我将从提供的文献中提取并结构化与遗传变异、疾病和实验方法相关的信息。以下是根据您提供的文献内容生成的JSON格式数据：

```json
{
    "Variants Include": [
        {
            "Gene": "SNCA",
            "variants": [
                {
                    "HGVS": "NM_000345.4:c.136G>A",
                    "cDNA Change": {
                        "transcript": "NM_000345.4",
                        "ref": "G",
                        "alt": "A",
                        "position": "136"
                    },
                    "Protein Change": {
                        "ref": "E",
                        "alt": "K",
                        "position": "46"
                    },
                    "Description in input context": "E46K mutation"
                },
                {
                    "HGVS": "NM_000345.4:c.89A>C",
                    "cDNA Change": {
                        "transcript": "NM_000345.4",
                        "ref": "A",
                        "alt": "C",
                        "position": "89"
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "P",
                        "position": "30"
                    },
                    "Description in input context": "A30P mutation"
                },
                {
                    "HGVS": "NM_000345.4:c.158A>G",
                    "cDNA Change": {
                        "transcript": "NM_000345.4",
                        "ref": "A",
                        "alt": "G",
                        "position": "158"
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "T",
                        "position": "53"
                    },
                    "Description in input context": "A53T mutation"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Dementia with Lewy bodies (DLB)",
        "MONDO": "MONDO:0002474"
    },
    "Experiment Method": [
        {
            "Assay Method": "Liposome pull-down assay",
            "Material used": {
                "Material Source": "Recombinant protein",
                "Material Name": "Recombinant human SNCA proteins",
                "Description": "Recombinant human SNCA proteins were used for the liposome pull-down assay."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.4:c.136G>A",
                    "Conclusion": "Increased",
                    "Molecular Effect": "Increased phospholipid binding",
                    "Result Description": "E46K mutation increased the binding of SNCA to type A liposomes by 88% and to type B liposomes by 56%."
                },
                {
                    "Variant": "NM_000345.4:c.89A>C",
                    "Conclusion": "Decreased",
                    "Molecular Effect": "Reduced phospholipid binding",
                    "Result Description": "A30P mutation reduced the binding of SNCA to type A liposomes by 95% and to type B liposomes by 53%."
                },
                {
                    "Variant": "NM_000345.4:c.158A>G",
                    "Conclusion": "No significant effect",
                    "Molecular Effect": "No significant effect on phospholipid binding",
                    "Result Description": "A53T mutation led to a non-significant 9–12% reduction in the binding of SNCA to both liposome types."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Three independent protein preparations were used."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Each sample was run in duplicate."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type SNCA was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "GST bound to beads was used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "3"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Filament assembly",
            "Material used": {
                "Material Source": "Recombinant protein",
                "Material Name": "Recombinant human SNCA proteins",
                "Description": "Recombinant human SNCA proteins were used for filament assembly experiments."
            },
            "Readout type": "Quantitative and Semi-quantitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.4:c.136G>A",
                    "Conclusion": "Increased",
                    "Molecular Effect": "Increased filament assembly",
                    "Result Description": "E46K SNCA showed a faster rate of assembly and a 2.5-fold greater total assembly than the wild-type protein at 98 h."
                },
                {
                    "Variant": "NM_000345.4:c.89A>C",
                    "Conclusion": "Decreased",
                    "Molecular Effect": "Slower filament assembly",
                    "Result Description": "A30P mutant had a slower rate of assembly than wild-type SNCA."
                },
                {
                    "Variant": "NM_000345.4:c.158A>G",
                    "Conclusion": "Increased",
                    "Molecular Effect": "Increased filament assembly",
                    "Result Description": "A53T mutant behaved similarly to E46K SNCA."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Three independent protein preparations were used."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Each sample was run in duplicate."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type SNCA was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "3"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}
```

### 解释
1. **Variants Include**: 提取了文献中提到的所有变异信息，并标准化了HGVS命名法。
2. **Described Disease**: 确定了研究的疾病为“路易体痴呆（DLB）”，并从MONDO数据库检索了相应的术语。
3. **Experiment Method**: 列出了所有提到的实验方法（脂质体拉下实验和丝状体组装实验），并详细描述了每种方法的材料来源、读出类型、结果描述、实验重复、对照设置、统计分析方法以及正常和异常结果的阈值。

请注意，对于未在文献中明确提及的内容（如统计分析方法、正常和异常结果的阈值等），使用了"N.D."表示未提及。如果您有更多具体要求或需要进一步调整，请告知。